(e)-n-(5-((e)-3-fluoro-6h-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-((r)-1-methyl-2-morpholin-4-yl-ethyl)-1,3-dihydro-benzoimidazol-2-ylidene)-urea and pharmaceutically acceptable salt thereof for use in therapy

摘要

The present invention provides a compound of Formula (I):
or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.